Lung cancer remains the leading cause of death from cancer in the U.S. and only 15 percent of patients with lung cancer are diagnosed with early stage disease.
Recent studies involving the use of low-dose CT of the chest suggest that screening can improve survival from early detection of lung cancer by as much as 20 percent.
For this reason, we partnered with St. Lukes University Hospital and Health Network when they launched a Lung Cancer Screening Program that offers low-cost service based on state-of-the-art screening methods for lung cancer in high-risk patients. This effort is backed by the support of a Multidisciplinary Lung Tumor Working Group and Tumor Board which is comprised of physicians in Medical Oncology, Pulmonology, dedicated Thoracic surgery, Radiation Oncology, Pathology and Radiology. This is a very unique group of physicians that have been working closely together for over a decade.